CardiacAssist Co-Founder Dr. George Magovern, Sr. to be Feted by Marquette University

Renowned thoracic and cardiovascular surgeon pioneered use of cardiac assist devices, among other notable achievements

Will receive 2010 Marquette All-University Alumni National Award for embodying “the mission of excellence, faith, leadership and service”

PITTSBURGH--(BUSINESS WIRE)-- CardiacAssist Inc. announced today that co-founder George Magovern, Sr., M.D., will be honored by his alma mater and receive the ‘2010 Marquette All-University Alumni National Award’ in a special ceremony at the university’s Milwaukee campus on Saturday, April 24th.

Dr. Magovern performed the first successful heart valve replacement in Pennsylvania in 1961, and developed a sutureless heart valve that reduced the time needed for heart-valve replacement while reducing the mortality rate of the procedure. In addition, Dr. Magovern performed the world’s second lung transplant, and pioneered clinical use of cardiac assist devices, among many other significant medical achievements.

Dr. Magovern also spent nearly 30 years teaching medical students, surgical residents and fellows as director of the Allegheny (Penn.) General Hospital thoracic surgery residency program, and was chairman of the hospital’s department of surgery for more than 25 years. He has authored more than 200 scientific articles, and served on the American Board of Thoracic Surgery and also as President of the Society of Thoracic Surgeons.

“Dr. Magovern played a critical role in the founding of CardiacAssist and development of TandemHeart, and thousands of very sick cardiac patients have benefited as a result,” said Michael Garippa, CEO and President of CardiacAssist. “We are very thankful for his vision, compassion and support.”

About CardiacAssist

Headquartered in Pittsburgh, privately held CardiacAssist is a growing and profitable medical technology company that develops, manufactures and markets cardiac assist devices. The Company has developed the world’s first and only proprietary platform, FDA-cleared and CE-Marked TandemHeart®, which provides a short-term extracorporeal circulatory support system for both cardiologists and cardiac surgeons.



CONTACT:

Ronald Trahan Associates, Inc.
Ron Trahan, APR, 508-359-4005, x108

KEYWORDS:   United States  North America  Pennsylvania

INDUSTRY KEYWORDS:   Education  University  Health  Cardiology  Hospitals  Medical Devices

MEDIA:

Logo
 Logo